Chapter 2 Literature Review
2.1 Venous Thromboembolism
2.1.1 Overview of Venous Thromboembolism
VTE refers to all forms of pathologic thrombosis occurring within the venous
circulation, represents a spectrum from simple superficial thrombophlebitis to fatal
pulmonary embolism. Most venous thrombosis occurs at the deep veins of the lower
extremities, giving rise to deep vein thrombosis (DVT). They also can occur in other
parts of body, including the veins of the upper extremities, pelvis, abdomen, and
cerebral venous sinuses. Pulmonary embolism (PE) is the most life-threatening
manifestation of VTE, which occurs when a clot dislodges from the site of formation
and embolizes into pulmonary arteries. Death from PE can occur within minutes after
the onset of symptoms, before effective treatment is given.19,20
2.1.2 Epidemiology of Venous Thromboembolism
The actual incidence of VTE is unknown because the disease is often clinically
silent. The annual incidence rate of VTE is reported to be 104-183 events per 100,000
persons in the Caucasian populations (Table 2.1).21-25 The annual incidence of VTE
increases markedly with age, from less than 5 cases per 100,000 persons under 15
year-old to 149 events per 100,000 persons over the age of 80.21
4
The prevalence of VTE varies among different ethnic cohorts. Compared to
Caucasian populations, the incidence of VTE is significantly higher among African-
American and significantly lower among Asian populations.22,26,27 Among Asian
populations, the estimated annual incidence of VTE is 14-57 per 100,000 persons (Table
2.1).8,10,28,29 The incidence ranges from 2.5 events per 100,000 person-years in those
younger than 30 years to 100 events per 100,000 person-years in those aged over 80
years.10 Although the annual incidence of VTE among Asian populations has been
perceived to be lower than Caucasian populations, it appears to be rapidly increasing.8,30
Along with rapid aging of the population, VTE is a major healthcare problem which
causing significant mortality, morbidity and healthcare resource expenditure in our
aging society.
Table 2.1 Incidence of venous thromboembolism reported in different populations Incidence per 100,000
Location Study design VTE DVT PE
America
Minnesota (Silverstein et al. 1998)21 California (only Caucasian)22 (White et al. 2005)
Worcester (Spencer et al. 2009)31
Population-based study
French (Oger et al. 2000)24 Norway (Naess et al. 2007)25
Population-based study
Hong Kong (Cheuk et al. 2004)28 Singapore (Molina et al. 2009)29 Taiwan (Lee et al. 2010)10 Korea (Jang et al. 2011)8
Population-based study
5
2.1.3 Risk Factors for Venous Thromboembolism
VTE is a multifactorial condition involving genetic and both constant and transient
acquired risk factors. In 1884, Virchow’s triad first described three primary factors
contribute to the formation of thrombosis: abnormalities in blood flow (venous stasis),
abnormalities in blood constituents (hypercoagulability), and abnormalities in the vessel
wall (vascular endothelial injury). Risk factors for VTE, include increasing age,
malignancy, prolonged immobility, major surgery, major trauma, prior VTE, chronic
heart failure, and inherited or acquired thrombophilia, alter one or more of the
components of the triad (Table 2.2).32 There is convincing evidence that the risk of VTE
increases in proportion to the number of predisposing factors.32,33
Compared with residents in the community, hospitalization without surgery or
nursing home confinement is associated with 8-folds increased risk of VTE.34
Hospitalization and nursing home residence together account for almost 60% of incident
VTE events occurring in the community, with hospitalization for medical illness and
hospitalization for surgery accounted for 22% and 24% of VTE, respectively.2
6
Table 2.2 Risk factors for venous thromboembolism Strong risk factors (odd ratio > 10)
Fracture (hip or leg) Hip or knee replacement Major general surgery Major trauma
Spinal cord injury
Moderate risk factors (odd ratio 2-9) Arthroscopic knee surgery
Central venous lines Chemotherapy
Congestive heart or respiratory failure Hormone replacement therapy
Weak risk factors (odd ratio < 2) Bed rest > 3 days
Immobility due to sitting (e.g. prolonged car or air travel) Increasing age
Laparoscopic surgery (e.g. cholecystectomy) Obesity
Pregnancy (antepartum) Varicose veins
Adapted from Anderson FA, Jr., Spencer FA. Risk factors for venous thromboembolism.
Circulation 2003;107:I9-16.
7
2.1.4 Complications of Venous Thromboembolism
VTE is an important worldwide healthcare burden associated with significant
morbidity and mortality. It is reported to be the third common cardiovascular causes of
death after myocardial infarction and stroke.35 The 1-week survival rate after a PE is
only 71%, and almost 25% of all cases of PE essentially present as sudden death.36 In
USA, 100,000-300,000 VTE-related deaths occur every year and PE had been declared
to be the most common preventable cause of hospital death and the significant target to
improve patient safety in hospitals.37
Recurrence of VTE is common. Despite anticoagulant therapy, about 30% of
patients develop recurrent VTE within the next ten years, with the highest recurrence
rate within the first year after their first VTE event.38,39 Men have a higher rate of
recurrence than women (relative risk of recurrent VTE: 1.6).40,41 In addition, survivors
of VTE always suffer from long-term complications, including post-thrombotic
syndrome and chronic thrombotic pulmonary hypertension. One-third to one-half of
patients with lower extremity DVT develop post-thrombotic syndrome during 20 years
of follow-up, characterized by pain and swelling, and in severe cases with venous
ulceration. These conditions can be disabling for patients and have great impact on
healthcare costs. Subsets of VTE patients require long-term anticoagulation to prevent
additional clots, which also decreases their quality of life and places them at an
8
increased risk for adverse bleeding episodes.37,38
2.1.5 Clinical Presentations of Venous Thromboembolism
The signs and symptoms of VTE are nonspecific. Furthermore, many patients with
VTE were asymptomatic. A leg DVT commonly presents with pain, erythema, and
swelling of the affected limb. Physical examination may show palpable cord, warmth,
and unilateral edema.42,43 Patients with upper extremity or neck DVT often complain
with upper extremity or head or neck swelling, erythema, and/or discomfort.44
Symptoms associated with PE depend on the degree of vascular obstruction, the
magnitude of inflammatory response, and the patient’s cardio-pulmonary reserve.
Patients may present with dyspnea, hypoxemia, tachycardia, pleuritic chest pain,
hemoptysis or even collapse with shock or pulseless electrical activity cardiac arrest.20,43
2.1.6 Diagnosis of Venous Thromboembolism
Duplex ultrasonography remains the test of choice in the investigation and
diagnosis of clinically suspected DVT. Although ultrasound is highly sensitive for the
detection of proximal DVT, it is less accurate for isolated DVT of the calf. The ideal
method, invasive venography, is used when a definitive answer is required. Newer
image modalities such as magnetic resonance venography and computerized
9
tomography (CT) scan can detect thrombosis of vessels proximal to the inguinal
ligament and intra-abdominal vessels. Another advantage of magnetic resonance
venography and CT scan is their ability to provide information about surrounding
structures that may lead to alternative diagnosis.20,42-44
Gold standard for the diagnosis of PE is pulmonary angiography, but it is an
invasive procedure that involves injection of contrast dye into pulmonary artery and
associated with 0.5% of mortality. Nowadays, CT scan has become the most commonly
used imaging test to diagnose PE. Before CT scan, ventilation-perfusion (V/Q) scan was
the first-line imaging modality of PE. Spiral CT scan can detect emboli in the
pulmonary arteries whereas V/Q scan measures the distribution of blood and air flow in
the lungs.20,42,43
10